Autologous peripheral blood stem cell transplantation should be considered first-line therapy in young patients with POEMS. The best protocol to collect peripheral blood stem cells remains to be defined, because of the disease rarity and the heterogeneity of published case series. We collected clinical and laboratory data from 25 patients undergoing mobilization, of whom 11 were mobilized using cyclophosphamide (CY) followed by granulocyte colony-stimulating factor (G-CSF) and 14 patients using G-CSF. The incidence of poor mobilization was low and not statistically different between the 2 groups. Both schemes (CY plus G-CSF versus G-CSF alone) were able to harvest a sufficient CD34+ cell dose.
Autore, F., Piccirillo, N., Nozza, A., Innocenti, I., Putzulu, R., Chiusolo, P., Sora', F., Zini Tanzi, G., Bacigalupo, A., Castagna, L., Sica, S., Bramanti, S., Laurenti, L., Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers, <<BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION>>, 2019; 25 (12): 2514-2516. [doi:10.1016/j.bbmt.2019.08.011] [http://hdl.handle.net/10807/142669]
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers
Autore, Francesco;Piccirillo, Nicola;Innocenti, Idanna;Putzulu, Rossana;Chiusolo, Patrizia;Sora', Federica;Zini Tanzi, Gina;Bacigalupo, Andrea;Sica, Simona;Laurenti, Luca
2019
Abstract
Autologous peripheral blood stem cell transplantation should be considered first-line therapy in young patients with POEMS. The best protocol to collect peripheral blood stem cells remains to be defined, because of the disease rarity and the heterogeneity of published case series. We collected clinical and laboratory data from 25 patients undergoing mobilization, of whom 11 were mobilized using cyclophosphamide (CY) followed by granulocyte colony-stimulating factor (G-CSF) and 14 patients using G-CSF. The incidence of poor mobilization was low and not statistically different between the 2 groups. Both schemes (CY plus G-CSF versus G-CSF alone) were able to harvest a sufficient CD34+ cell dose.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
